Compare WPRT & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WPRT | INMB |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.7M | 34.3M |
| IPO Year | 2006 | 2018 |
| Metric | WPRT | INMB |
|---|---|---|
| Price | $1.98 | $1.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $4.50 | $4.30 |
| AVG Volume (30 Days) | 42.8K | ★ 464.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $14,000.00 |
| Revenue This Year | N/A | $264.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.54 | $1.21 |
| 52 Week High | $4.25 | $11.64 |
| Indicator | WPRT | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 40.87 |
| Support Level | $1.85 | $1.21 |
| Resistance Level | $2.12 | $1.71 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 43.39 | 38.84 |
Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.